**Question:** A patient comes to the clinic requesting a tuberculin skin test as a part of his preemployment check-up. All of the following are methods of tuberculin testing except

A. **Option A:** Mantoux test (intradermal injection)
B. **Option B:** Tuberculin purified protein derivative (PPD)
C. **Option C:** Tuberculin bacillus Calmette-Guérin (BCG) vaccination
D. **Option D:** Tuberculin interferon-gamma release assay (IGRA)

**Core Concept:**

Tuberculosis (TB) is a communicable respiratory disease caused by infections with Mycobacterium tuberculosis. Diagnosing TB is crucial, especially in preemployment screening, as it helps identify potential carriers or infected individuals. Two main methods for tuberculin testing are:

1. Mantoux test: This involves intradermal injection of tuberculin purified protein derivative (PPD) into the patient's forearm. The test measures the skin reaction, usually after 48-72 hours, to evaluate T cell response to M. tuberculosis.
2. Tuberculin interferon-gamma release assay (IGRA): This is a blood test measuring interferon-gamma release after M. tuberculosis-specific antigens stimulation. IGRAs are helpful when Mantoux test is contraindicated (e.g., in immunocompromised patients or those with prior BCG vaccination).

**Why the Correct Answer is Right:**

Option C, **Tuberculin bacillus Calmette-Guérin (BCG) vaccination**, is not considered a true tuberculin test. BCG vaccination is an immune response to a live attenuated Mycobacterium bovis strain and is used primarily as a vaccine against severe forms of TB in children and individuals at high risk. Since BCG vaccination provides immunity against TB caused by Mycobacterium bovis, it doesn't serve as a diagnostic tool for M. tuberculosis infection or TB disease.

**Why Other Options are Wrong:**

Option A, **Mantoux test**, is a valid tuberculin test, as it measures the skin reaction to PPD, a key component of the tuberculin test. This method is frequently used for diagnosing TB infection or disease, especially in individuals who are unable to give blood samples for IGRAs (e.g., immunocompromised patients or those with previous BCG vaccination).

Option B, **Tuberculin interferon-gamma release assay (IGRA)**, is a blood test measuring interferon-gamma release after M. tuberculosis-specific antigens stimulation. IGRAs are alternatives to the Mantoux test, particularly in situations where the Mantoux test may be inappropriate (e.g., immunocompromised patients or those with previous BCG vaccination).

Option D, **Tuberculin interferon-gamma release assay (IGRA)**, is also a blood test measuring interferon-gamma release after M. tuberculosis-specific antigens stimulation. IGRAs are alternatives to the Mantoux test, particularly in situations where the Mantoux test may be inappropriate (e.g., immunocompromised patients or those with